Cargando…
Avoidance of surgery for head and neck infantile myofibromatosis using imatinib monotherapy
Describe a novel use for a kinase inhibitor, imatinib, in young children with a known activated somatic mutation in PDGFR‐beta. Two patients with infantile myofibromatosis treated with imatinib. Case description of evaluation, diagnosis and treatment decisions for infantile myfibromatosis of the hea...
Autores principales: | Pattisapu, Prasanth, Wenger, Tara L., Dahl, John P., Bly, Randall A., Bonilla‐Velez, Juliana, Wu, Natalie, Hall, Anurekha, Rudzinski, Erin R., Perkins, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826127/ https://www.ncbi.nlm.nih.gov/pubmed/35154723 http://dx.doi.org/10.1002/ccr3.5382 |
Ejemplares similares
-
Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib
por: Hassan, Mohammed, et al.
Publicado: (2019) -
Infantile myofibromatosis
por: Larralde, Margarita, et al.
Publicado: (2017) -
Aggressive infantile myofibromatosis with intestinal involvement
por: Römer, Tristan, et al.
Publicado: (2021) -
Spontaneous Remission of Solitary-Type Infantile Myofibromatosis
por: Kikuchi, Kazuhiro, et al.
Publicado: (2011) -
Solitary infantile myofibromatosis in the upper extremities: Case report
por: Najwa, Amsiguine, et al.
Publicado: (2023)